Granted Patent B2

US 8,795,966 · App. 12/708,362 · Granted Aug 5, 2014

Abstract

Claims (37)

1. A method comprising the steps of:

providing a set of oligonucleotide probes bound to a substrate, wherein each probe comprises

a target binding domain, which is complementary to a target nucleic acid;

a closing domain with a sequence that is complementary to the sequence of the target binding domain; and

a joining region between the binding domain and the closing domain, which is not complementary to the target nucleic acid;

wherein the set comprises at least two probes that differ in the sequence of their target binding domain, and wherein the probes are bound to the substrate via the joining region;

placing the set of probes in contact with nucleic acid targets under conditions suitable for capture of the target by a probe and formation of a probe-target duplex;

generating conditions suitable for enzyme-mediated probe elongation wherein the 3′ terminal end of a probe is elongated if a nucleotide in the target sequence which is aligned with the 3′ terminal end of the target binding domain is complementary; and

detecting the increase in cumulative signal associated with each type of probe, resulting from probe elongation.

2. The method of claim 1 wherein the signal is associated with labeled nucleotides incorporated into the elongated probe.

3. The method of claim 2 wherein labeled dNTPs or ddNTPs are incorporated into the elongated probe.

4. The method of claim 1 wherein detection of elongation is performed by conducting a thermal stability analysis, by cycling to a temperature above the de-annealing temperature of non-elongated duplexes and then monitoring probe fluorescence to determine probe-target-associated fluorescence.

5. A method comprising:

providing a plurality of oligonucleotide probes bound to a substrate, wherein each probe comprises

a target binding domain, which is complementary to a target nucleic acid;

a closing domain with a sequence that is complementary to the sequence of the target binding domain; and

a joining region between the binding domain and the closing domain, which is not complementary to the target nucleic acid;

wherein the set comprises at least two probes that differ in the sequence of their target binding domain, and wherein the probes are bound to the substrate via the joining region;

placing the probes in contact with a solution containing target nucleic acids under conditions where a target nucleic acid forms a duplex with the target binding domain of a probe; and

stabilizing the duplex by elongating the 3′ terminal ends of probes that have a nucleotide in the target sequence aligned with a complementary nucleotide in the target binding.

6. A method comprising:

providing a plurality of oligonucleotide probes bound to a substrate, wherein each probe comprises

a target binding domain, which is complementary to a target nucleic acid;

a closing domain with a sequence that is complementary to the sequence of the target binding domain; and

a joining region between the binding domain and the closing domain, which is not complementary to the target nucleic acid;

wherein the set comprises at least two probes that differ in the sequence of their target binding domain, and wherein the probes are bound to the substrate via the joining region;

placing the probes in contact with a solution containing target nucleic acids under conditions that permit binding of the target nucleic acids to a target binding domain so as to form probe-target complexes;

adjusting assay conditions so as to permit stabilization of probe-target complexes by target-mediated enzymatic elongation; and

detecting the presence of probe-target complexes by monitoring probe fluorescence from the target-associated state of the probe and comparing it to the pre-assay signal.

7. The method of claim 6 , further comprising increasing the effective concentration of the targets available for binding to the probes by one or more of the following: (i) adjusting the solution's ionic strength to greater than a threshold; (ii) selecting a target domain of a size less than a threshold; or (iii) selecting target domains within a specified proximity to a terminal end of the targets.

8. The method of claim 7 , wherein the ionic strength threshold corresponds to a buffer concentration of 50 mM salt.

9. The method of claim 5 or 6 wherein the reaction time is selected to reflect the stringency of the imposed conditions, the stringency determining the probability of random formation of a probe-target-enzyme-substrate intermediate state in the formation of elongation product, such that a sufficient number of stable elongated duplex states are capable of being formed.

10. The method of any of claims 1 , 5 , or 6 , wherein the substrate is a microparticle.

11. The method of claim 10 , wherein more than one type of oligonucleotide probe is bound to each microparticle.

12. The method of claim 5 , or 6 , wherein the ionic strength of the solution is increased by adding salt.

13. The method of any of claim 1 , 5 , or 6 , wherein the target binding domain is fully complementary to the target.

14. The method of any of claim 1 , 5 , or 6 , wherein the oligonucleotide probes and the nucleic acid targets can either be DNA or RNA.

Assignments (7)